- Home
- VRNT vs SANA Comparison
VRNT vs SANA Comparison
Compare VRNT & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNT
- SANA
- Stock Information
- Founded
- VRNT 1994
- SANA 2018
- Country
- VRNT United States
- SANA United States
- Employees
- VRNT N/A
- SANA N/A
- Industry
- VRNT EDP Services
- SANA Medicinal Chemicals and Botanical Products
- Sector
- VRNT Technology
- SANA Health Care
- Exchange
- VRNT Nasdaq
- SANA Nasdaq
- Market Cap
- VRNT 1.2B
- SANA 983.4M
- IPO Year
- VRNT N/A
- SANA 2021
- Fundamental
- Price
- VRNT $20.33
- SANA $3.27
- Analyst Decision
- VRNT Hold
- SANA Strong Buy
- Analyst Count
- VRNT 6
- SANA 5
- Target Price
- VRNT $25.60
- SANA $8.75
- AVG Volume (30 Days)
- VRNT 2.9M
- SANA 4.3M
- Earning Date
- VRNT 09-02-2025
- SANA 11-07-2025
- Dividend Yield
- VRNT N/A
- SANA N/A
- EPS Growth
- VRNT 10.62
- SANA N/A
- EPS
- VRNT 0.74
- SANA N/A
- Revenue
- VRNT $893,843,000.00
- SANA N/A
- Revenue This Year
- VRNT $7.74
- SANA N/A
- Revenue Next Year
- VRNT $5.56
- SANA N/A
- P/E Ratio
- VRNT $27.61
- SANA N/A
- Revenue Growth
- VRNT N/A
- SANA N/A
- 52 Week Low
- VRNT $14.15
- SANA $1.26
- 52 Week High
- VRNT $34.80
- SANA $7.30
- Technical
- Relative Strength Index (RSI)
- VRNT 50.72
- SANA 49.81
- Support Level
- VRNT $20.30
- SANA $2.87
- Resistance Level
- VRNT $20.37
- SANA $3.42
- Average True Range (ATR)
- VRNT 0.08
- SANA 0.24
- MACD
- VRNT 0.03
- SANA 0.04
- Stochastic Oscillator
- VRNT 63.46
- SANA 57.87
About VRNT Verint Systems Inc.
Verint Systems Inc with its subsidiaries, helps brands provide Boundless customer experience (CX) automation. AI offers a solution, and that's where Verint comes in. It empowers brands with groundbreaking AI via a next-gen open platform. Its Verint Open Platform helps organizations increase CX automation to achieve their strategic objectives and realize ROI. Geographically, it derives a majority of its revenue from the United States.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.